Acquisition of cytomegalovirus infection by premature neonates

C R de Cates1, J Gray, N R Roberton

  • 1Neonatal Unit, Rosie Maternity Hospital, Cambridge, U.K.

The Journal of Infection
|January 1, 1994
PubMed

Insights

Premature infants are at risk for cytomegalovirus (CMV) infection. Transfusing with CMV antibody-negative blood significantly reduces infection risk in these vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatric Hematology

Background:

  • Cytomegalovirus (CMV) poses a significant risk to premature infants, particularly those born at 32 weeks gestation or less.
  • Understanding transmission routes and risk factors for acquired CMV infection in neonates is crucial for prevention strategies.

Purpose of the Study:

  • To evaluate the risk of premature infants acquiring cytomegalovirus (CMV) infection.
  • To determine the impact of blood transfusions on CMV acquisition in this high-risk population.

Main Methods:

  • Prospective study of infants ≤ 32 weeks gestation admitted to a neonatal unit.
  • Infants assessed at birth for congenital CMV infection and followed to 1 month post-term.
  • CMV infection acquisition analyzed based on maternal CMV antibody status and infant blood transfusion history.

Main Results:

  • 12.2% (16/131) of infants acquired CMV infection.
  • CMV acquisition was significantly higher in transfused infants: 9.23% (6/65) for those born to CMV-negative mothers and 26.47% (9/34) for those born to CMV-positive mothers.
  • The relative risk of CMV acquisition associated with blood transfusion was 3.7.

Conclusions:

  • Blood transfusions are a significant risk factor for acquired CMV infection in premature infants.
  • All premature infants requiring blood transfusions should receive CMV antibody-negative blood, irrespective of maternal CMV immune status.
  • Implementing CMV-screened blood transfusions can reduce infection rates in vulnerable neonatal populations.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...